Volume 152, Issue 8, Pages (June 2017)

Slides:



Advertisements
Similar presentations
Volume 342, Issue 1, Pages (January 2014)
Advertisements

Volume 133, Issue 1, Pages (July 2007)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Molecular Therapy - Nucleic Acids
Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a Cell Physiol Biochem.
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
Volume 146, Issue 5, Pages (May 2014)
Volume 15, Issue 6, Pages (June 2009)
Volume 152, Issue 8, Pages (June 2017)
Volume 68, Issue 1, Pages e6 (October 2017)
Volume 144, Issue 3, Pages e4 (March 2013)
Volume 145, Issue 4, Pages e9 (October 2013)
Integrin αvβ6 Promotes Lung Cancer Proliferation and Metastasis through Upregulation of IL-8–Mediated MAPK/ERK Signaling  Pengwei Yan, Huanfeng Zhu, Li.
Volume 143, Issue 3, Pages e2 (September 2012)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non–Small Cell Lung Cancer Patients 
Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP  Hui Wang, Kai Li, Yu Mei, Xuemei Huang, Zhenglin Li, Qingzhu.
Volume 133, Issue 1, Pages (July 2007)
Volume 136, Issue 3, Pages e4 (March 2009)
Volume 152, Issue 8, Pages (June 2017)
Volume 136, Issue 2, Pages e1 (February 2009)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 138, Issue 3, Pages e2 (March 2010)
Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC  Guanming Jiao, Qi Huang, Muren Hu, Xuchun Liang, Fuchen Li, Chunling.
Volume 145, Issue 4, Pages e9 (October 2013)
Volume 154, Issue 8, Pages e1 (June 2018)
Volume 146, Issue 7, Pages e5 (June 2014)
Volume 9, Issue 2, Pages (August 2017)
Volume 141, Issue 6, Pages (December 2011)
Volume 142, Issue 3, Pages e3 (March 2012)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Molecular Therapy - Nucleic Acids
Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer
Volume 19, Issue 12, Pages (December 2017)
Volume 132, Issue 4, Pages (April 2007)
Volume 68, Issue 1, Pages e6 (October 2017)
Volume 146, Issue 5, Pages (May 2014)
Volume 130, Issue 7, Pages (June 2006)
Volume 147, Issue 5, Pages (November 2014)
A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies  Xingyi Guo,
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 53, Issue 5, Pages (March 2014)
Volume 8, Issue 6, Pages (September 2014)
Volume 137, Issue 1, Pages (July 2009)
Volume 142, Issue 7, Pages e2 (June 2012)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 156, Issue 4, Pages e8 (March 2019)
Integrative Functional Genomics Implicates EPB41 Dysregulation in Hepatocellular Carcinoma Risk  Xinyu Yang, Dianke Yu, Yanli Ren, Jinyu Wei, Wenting.
MiR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling  Hua Jin, Song Luo, Yun Wang, Chang Liu, Zhenghao.
Fine mapping the MHC region identified rs as a new variant associated with nonobstructive azoospermia in Han Chinese males  Mingtao Huang, M.D.,
Volume 147, Issue 5, Pages (November 2014)
miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Volume 132, Issue 4, Pages (April 2007)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang  Molecular Therapy 
A LIN28B Tumor-Specific Transcript in Cancer
Volume 25, Issue 4, Pages (April 2017)
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.
LncRNA TRERNA1 Function as an Enhancer of SNAI1 Promotes Gastric Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition  Huazhang Wu, Ying.
MiR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1  Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin.
Molecular Therapy - Nucleic Acids
SiRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin  Shuquan Zheng, Xiaoxia Wang, Yu-Hua.
Volume 22, Issue 9, Pages (September 2014)
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
The prostate cancer risk variant rs regulates multiple gene expression through extreme long-range chromatin interaction to control tumor progression.
Volume 24, Issue 10, Pages (October 2016)
Volume 53, Issue 5, Pages (March 2014)
Volume 129, Issue 2, Pages (August 2005)
Presentation transcript:

Volume 152, Issue 8, Pages 2011-2021 (June 2017) Exome Array Analysis Identifies Variants in SPOCD1 and BTN3A2 That Affect Risk for Gastric Cancer  Meng Zhu, Caiwang Yan, Chuanli Ren, Xiaodan Huang, Xun Zhu, Haiyong Gu, Meilin Wang, Shouyu Wang, Yong Gao, Yong Ji, Xiaoping Miao, Ming Yang, Jinfei Chen, Jiangbo Du, Tongtong Huang, Yue Jiang, Juncheng Dai, Hongxia Ma, Jianwei Zhou, Zhaoming Wang, Zhibin Hu, Guozhong Ji, Zhengdong Zhang, Hongbing Shen, Yongyong Shi, Guangfu Jin  Gastroenterology  Volume 152, Issue 8, Pages 2011-2021 (June 2017) DOI: 10.1053/j.gastro.2017.02.017 Copyright © 2017 AGA Institute Terms and Conditions

Figure 1 SPOCD1 promotes gastric cancer malignant cellular phenotypes. (A) EdU proliferation analysis of the effect of SPOCD1 on the growth of SPOCD1 knockout (SPOCD1-/-) or negative control (WT) in BGC823 cells. (B) Colony formation assay of BGC823 cells with knockout of SPOCD1 or negative control. The numbers of colonies were counted and were presented in a histogram. (C) Representative images (top) and quantification (bottom) of transwell migration and invasion assays in BGC823 cells after knockout of SPOCD1 or in negative control. (D–F) Overexpression of SPOCD1 in knockout SPOCD1-/- BGC823 cells rescued the vitalities of cell proliferation, colony formation, migration, and invasion. Representative images (top) and quantification (bottom) are shown in colony formation and transwell (migration or invasion) assays. Error bars represent SEM, n = 3. All experiments were performed at least 3 times and data analysis was conducted by 2-sided t-test. **P < .01, ***P < .001. Gastroenterology 2017 152, 2011-2021DOI: (10.1053/j.gastro.2017.02.017) Copyright © 2017 AGA Institute Terms and Conditions

Figure 2 SPOCD1 knockout suppresses tumorigenicity of gastric cancer cells in nude mice. In vivo xenograft tumor formation assays were performed using SPOCD1 knockout (SPOCD1-/-) and negative control (WT) cells (5.0 × 106) subcutaneously injected into the bilateral armpit (left: WT; right: SPOCD1-/-) of 5-week-old male BALB/C nude mice. Tumor growth was measured twice a week. At day 14, mice were sacrificed and tumors were photographed. (A) Photograph of excised tumor tissues from mice (top, tumors from WT; bottom, tumors from SPOCD1-/-). (B) Mean volumes of xenograft tumors in WT or SPOCD1-/- groups. (C) Average tumor weight of WT or SPOCD1-/- groups when the tumors were harvested. Data analysis was conducted by 2-sided t-test. *P < .05; **P < .01. Gastroenterology 2017 152, 2011-2021DOI: (10.1053/j.gastro.2017.02.017) Copyright © 2017 AGA Institute Terms and Conditions

Figure 3 The variant haplotype of rs2799077-T– rs2799079-C reduces BTN3A2 expression through reducing an enhancer activity. (A–B) The expression quantitative trait loci analysis between rs1679709 and BTN3A2 in GTEx and TCGA. (C) Active epigenetic signature of chromatin at the 6p22.1 locus. Top, LD analysis of 100-kb region around rs1679709 based on CHB of 1000 Genomes Project data. Bottom, 2 single nucleotide polymorphisms (rs2799077 and rs2799079) were annotated into an enhancer region based on H3K27AC ChIP-seq data from ENCODE and Gene Expression Omnibus (GSM1102783 and GSM1102794). (D) Luciferase reporter assay for BTN3A2 enhancer region. The minor alleles of rs2799077 and rs2799079 are underlined. All constructs were cotransfected with pRL-SV40 to standardize the transfection efficiency. The results of luciferase activity were normalized by PGL3 promoter. (E) Expression level of BTN3A2 was measured by qRT-polymerase chain reaction in BGC823 cells with and without deletion of enhancer region. Error bars in D and E represent SEM. P values were derived from t-tests: *P < .05, **P < .01. Gastroenterology 2017 152, 2011-2021DOI: (10.1053/j.gastro.2017.02.017) Copyright © 2017 AGA Institute Terms and Conditions

Figure 4 BTN3A2 promotes gastric cancer cellular malignant phenotypes. (A–C) Knockout of BTN3A2 (BTN3A2-/-) reduced cell proliferation, colony formation, migration, and invasion of BGC823 cells. (D–F) Overexpression of BTN3A2 in the BTN3A2-/- BGC823 cells rescued the vitalities of cell proliferation, colony formation, migration, and invasion. Representative images (top) and quantification (bottom) are shown in colony formation and transwell (migration or invasion) assays. Error bars represent SEM, n = 3. All experiments were performed at least 3 times and 2-sided t-test was used for analysis. **P < .01, ***P < .001. Gastroenterology 2017 152, 2011-2021DOI: (10.1053/j.gastro.2017.02.017) Copyright © 2017 AGA Institute Terms and Conditions